[Experimental alpha-chymotrypsin model of glaucoma in the rabbit: histopathological studies (author's transl)]
- PMID: 521608
[Experimental alpha-chymotrypsin model of glaucoma in the rabbit: histopathological studies (author's transl)]
Abstract
The injection of alpha-chymotrypsin into the posterior chamber of the eye is known to produce an experimental ocular hypertension of long duration in animals. The present study reports the pathological changes which occur in the eye during the first nine months after the ocular injection of alpha-chymotrypsin in rabbits. Six weeks after treatment most of the eyes showed a buphthalmia and an intraocular pressure elevation which varied greatly from animal to animal. The anterior chamber angle of the treated eyes showed a progressive enlargement. Several days after the enzyme injection a transient increase in thickness of the cornea and Descemet membrane was noted. Cupping of the optic disc, characterized by a total disappearance of the optic nerve head fibers and an excavation beginning at margins of the retina appeared after four months and in most cases were present seven months after the treatment. More or less prominent retinal degeneration was also evidenced three months after enzyme injection. The results indicate alpha-chymotrypsin-induced occular hypertension in the rabbit leads after several months to pathological change in the eye analogous to that observed in human glaucoma.
Similar articles
-
Experimental alphachymotrypsin glaucoma.Ann Ophthalmol. 1975 Jun;7(6):803-10. Ann Ophthalmol. 1975. PMID: 1147507
-
Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, II: Structural measures.Invest Ophthalmol Vis Sci. 2004 Aug;45(8):2640-51. doi: 10.1167/iovs.03-0567. Invest Ophthalmol Vis Sci. 2004. PMID: 15277487
-
Morphometric evaluation of changes with time in optic disc structure and thickness of retinal nerve fibre layer in chronic ocular hypertensive monkeys.Exp Eye Res. 2006 Mar;82(3):427-40. doi: 10.1016/j.exer.2005.08.001. Epub 2006 Jan 4. Exp Eye Res. 2006. PMID: 16388801
-
[Fine structural changes in the trabecular meshwork of the human eye in different forms of glaucoma (author's transl)].Klin Monbl Augenheilkd. 1973 Oct;163(4):401-10. Klin Monbl Augenheilkd. 1973. PMID: 4590839 Review. German. No abstract available.
-
Ocular hypertension or early undetected glaucoma?J Am Optom Assoc. 1987 Sep;58(9):747-69. J Am Optom Assoc. 1987. PMID: 3328751 Review.
Cited by
-
Nanomedicine in Ophthalmology: From Bench to Bedside.J Clin Med. 2024 Dec 16;13(24):7651. doi: 10.3390/jcm13247651. J Clin Med. 2024. PMID: 39768574 Free PMC article. Review.
-
R-enantiomer of timolol: a potential selective ocular antihypertensive agent.Graefes Arch Clin Exp Ophthalmol. 1984;221(5):234-8. doi: 10.1007/BF02134145. Graefes Arch Clin Exp Ophthalmol. 1984. PMID: 6092239
-
Comparison of different models for the testing of pilocarpine eyedrops using conventional eyedrops and a novel depot formulation (nanoparticles).Graefes Arch Clin Exp Ophthalmol. 1989;227(2):188-93. doi: 10.1007/BF02169795. Graefes Arch Clin Exp Ophthalmol. 1989. PMID: 2721988